Product Information

DIFLUPREDNATE 0.05% EYE DROP is a generic product labeled by Sandoz Inc., priced at $9.0744 per ML under NDC 00781600078. Its NADAC has been published 256 times since Dec 22, 2021.

FDA first approved this application on Jun 23, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DIFLUPREDNATE 0.05% EYE DROP

Difluprednate Ophthalmic
$9.0744per ML

Strength

.5 mg/mL

Manufacturer

Sandoz Inc.

NDC

00781600078

Classification

Generic

Dosage Form

EMULSION

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

DIFLUPREDNATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA022212

FDA Approved

6/23/2008

TE Code

AB

On Market Since

5/15/2013

Price Statistics

The NADAC for DIFLUPREDNATE 0.05% EYE DROP has been published 256 times since Dec 22, 2021, and over the history we have for it it has declined 72.8%. The table below summarizes its recorded NADAC range and movement.

Current price$9.0744 per ML
All-time high$33.3087 (Jan 12, 2022)
All-time low$7.0479 (Jun 17, 2026)
52-week high$10.4599
52-week low$7.0479
Median price$14.3420
Average price$15.9183
Largest weekly change+46.0% (Aug 21, 2024)
Weeks tracked256
Tracking sinceDec 22, 2021

Price History

1W

0.0%

1M

-6.3%

3M

+22.5%

6M

+5.3%

1Y

-8.6%

3Y

-46.2%

5Y

N/A

All

-72.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DIFLUPREDNATE 0.05% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for DIFLUPREDNATE 0.05% EYE DROP, manufactured by Sandoz Inc., is $9.0744 per ML (NDC 00781600078), effective Nov 11, 2026.

How has the price of DIFLUPREDNATE 0.05% EYE DROP changed over time?

Over the history we have for it, the NADAC for DIFLUPREDNATE 0.05% EYE DROP has declined 72.8%. It has been tracked across 256 weekly CMS publications since Dec 22, 2021.

What are the highest and lowest recorded NADAC prices for DIFLUPREDNATE 0.05% EYE DROP?

Since Dec 22, 2021, the NADAC for DIFLUPREDNATE 0.05% EYE DROP has ranged from a low of $7.0479 (Jun 17, 2026) to a high of $33.3087 (Jan 12, 2022), with a median of $14.3420 per ML.

Are there cheaper alternatives to DIFLUPREDNATE 0.05% EYE DROP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DIFLUPREDNATE 0.05% EYE DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures DIFLUPREDNATE 0.05% EYE DROP?

DIFLUPREDNATE 0.05% EYE DROP (NDC 00781600078) is labeled by Sandoz Inc., and CMS classifies it as a generic product.